• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Viewpoints > On World Meningitis Day, too many people are dying of cryptococcal meningitis in Africa > Page 5

On World Meningitis Day, too many people are dying of cryptococcal meningitis in Africa

7 Oct 2024

By Justine Odionyi, Head of Disease, HIV, DNDi

When Zikhona, a young woman from New Crossroads in Cape Town, arrived at Khayelitsha Hospital, she thought she was going to die. She was in severe pain, had an excruciating, crippling headache, a stiff neck, and was almost blind. She was diagnosed with cryptococcal meningitis – a disease she never heard of before. Fortunately, she received treatment in time and survived.

But many people don’t not have this chance. Every year, around 180,000 people with HIV die from cryptococcal meningitis – 135,000 of them in sub-Saharan Africa.

As an HIV clinician and researcher, I have witnessed first-hand the devastation brought by this disease. And I am outraged, because I know that most of these deaths could be avoided. Many people with cryptococcal meningitis die simply because they aren’t diagnosed or can’t access the treatment that could save their life.

Read the viewpoint published in African Arguments

Registration & access Cryptococcal meningitis Africa

Read, watch, share

Loading...
Statements
12 Feb 2025

DNDi statement on recent US government executive actions and the escalating retreat from global health and medical research

DNDi and African Union teams at the MoU signing
Press releases
10 Feb 2025

The African Union Commission Strengthens Collaboration with the Drugs for Neglected Diseases initiative

Statements
5 Feb 2025

DNDi interventions at the 156th Session of the WHO Executive Board

Lab activities
Press releases
4 Feb 2025

Hyundai Bio (HDB) and DNDi sign MOU for joint development of Xafty-based dengue treatment

Videos
30 Jan 2025

Bölët Mouna! Ending sleeping sickness in Guinea

Fishermen in canoes on the river
Stories
30 Jan 2025

Inside Guinea’s quest to eliminate sleeping sickness

Press releases
30 Jan 2025

IRD, DNDi and Institut Pasteur welcome the WHO validation for the elimination of sleeping sickness in Guinea

Laboratory activities
Press releases
30 Jan 2025

DNDi welcomes GHIT support for new collaboration with Eisai for dengue and Zika virus disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License